Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.

<h4>Background</h4>Highly charged compounds typically suffer from low membrane permeability and thus are generally regarded as sub-optimal drug candidates. Nonetheless, the highly charged drug fosmidomycin and its more active methyl-derivative FR900098 have proven parasiticidal activity...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stefan Baumeister, Jochen Wiesner, Armin Reichenberg, Martin Hintz, Sven Bietz, Omar S Harb, David S Roos, Maximilian Kordes, Johannes Friesen, Kai Matuschewski, Klaus Lingelbach, Hassan Jomaa, Frank Seeber
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c4027a7c21c4431683f79eb680d83406
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4027a7c21c4431683f79eb680d83406
record_format dspace
spelling oai:doaj.org-article:c4027a7c21c4431683f79eb680d834062021-11-18T06:54:28ZFosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.1932-620310.1371/journal.pone.0019334https://doaj.org/article/c4027a7c21c4431683f79eb680d834062011-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21573242/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Highly charged compounds typically suffer from low membrane permeability and thus are generally regarded as sub-optimal drug candidates. Nonetheless, the highly charged drug fosmidomycin and its more active methyl-derivative FR900098 have proven parasiticidal activity against erythrocytic stages of the malaria parasite Plasmodium falciparum. Both compounds target the isoprenoid biosynthesis pathway present in bacteria and plastid-bearing organisms, like apicomplexan parasites. Surprisingly, the compounds are inactive against a range of apicomplexans replicating in nucleated cells, including Toxoplasma gondii.<h4>Methodology/principal findings</h4>Since non-infected erythrocytes are impermeable for FR90098, we hypothesized that these drugs are taken up only by erythrocytes infected with Plasmodium. We provide evidence that radiolabeled FR900098 accumulates in theses cells as a consequence of parasite-induced new properties of the host cell, which coincide with an increased permeability of the erythrocyte membrane. Babesia divergens, a related parasite that also infects human erythrocytes and is also known to induce an increase in membrane permeability, displays a similar susceptibility and uptake behavior with regard to the drug. In contrast, Toxoplasma gondii-infected cells do apparently not take up the compounds, and the drugs are inactive against the liver stages of Plasmodium berghei, a mouse malaria parasite.<h4>Conclusions/significance</h4>Our findings provide an explanation for the observed differences in activity of fosmidomycin and FR900098 against different Apicomplexa. These results have important implications for future screens aimed at finding new and safe molecular entities active against P. falciparum and related parasites. Our data provide further evidence that parasite-induced new permeability pathways may be exploited as routes for drug delivery.Stefan BaumeisterJochen WiesnerArmin ReichenbergMartin HintzSven BietzOmar S HarbDavid S RoosMaximilian KordesJohannes FriesenKai MatuschewskiKlaus LingelbachHassan JomaaFrank SeeberPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 5, p e19334 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Stefan Baumeister
Jochen Wiesner
Armin Reichenberg
Martin Hintz
Sven Bietz
Omar S Harb
David S Roos
Maximilian Kordes
Johannes Friesen
Kai Matuschewski
Klaus Lingelbach
Hassan Jomaa
Frank Seeber
Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
description <h4>Background</h4>Highly charged compounds typically suffer from low membrane permeability and thus are generally regarded as sub-optimal drug candidates. Nonetheless, the highly charged drug fosmidomycin and its more active methyl-derivative FR900098 have proven parasiticidal activity against erythrocytic stages of the malaria parasite Plasmodium falciparum. Both compounds target the isoprenoid biosynthesis pathway present in bacteria and plastid-bearing organisms, like apicomplexan parasites. Surprisingly, the compounds are inactive against a range of apicomplexans replicating in nucleated cells, including Toxoplasma gondii.<h4>Methodology/principal findings</h4>Since non-infected erythrocytes are impermeable for FR90098, we hypothesized that these drugs are taken up only by erythrocytes infected with Plasmodium. We provide evidence that radiolabeled FR900098 accumulates in theses cells as a consequence of parasite-induced new properties of the host cell, which coincide with an increased permeability of the erythrocyte membrane. Babesia divergens, a related parasite that also infects human erythrocytes and is also known to induce an increase in membrane permeability, displays a similar susceptibility and uptake behavior with regard to the drug. In contrast, Toxoplasma gondii-infected cells do apparently not take up the compounds, and the drugs are inactive against the liver stages of Plasmodium berghei, a mouse malaria parasite.<h4>Conclusions/significance</h4>Our findings provide an explanation for the observed differences in activity of fosmidomycin and FR900098 against different Apicomplexa. These results have important implications for future screens aimed at finding new and safe molecular entities active against P. falciparum and related parasites. Our data provide further evidence that parasite-induced new permeability pathways may be exploited as routes for drug delivery.
format article
author Stefan Baumeister
Jochen Wiesner
Armin Reichenberg
Martin Hintz
Sven Bietz
Omar S Harb
David S Roos
Maximilian Kordes
Johannes Friesen
Kai Matuschewski
Klaus Lingelbach
Hassan Jomaa
Frank Seeber
author_facet Stefan Baumeister
Jochen Wiesner
Armin Reichenberg
Martin Hintz
Sven Bietz
Omar S Harb
David S Roos
Maximilian Kordes
Johannes Friesen
Kai Matuschewski
Klaus Lingelbach
Hassan Jomaa
Frank Seeber
author_sort Stefan Baumeister
title Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
title_short Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
title_full Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
title_fullStr Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
title_full_unstemmed Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
title_sort fosmidomycin uptake into plasmodium and babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/c4027a7c21c4431683f79eb680d83406
work_keys_str_mv AT stefanbaumeister fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT jochenwiesner fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT arminreichenberg fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT martinhintz fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT svenbietz fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT omarsharb fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT davidsroos fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT maximiliankordes fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT johannesfriesen fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT kaimatuschewski fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT klauslingelbach fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT hassanjomaa fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
AT frankseeber fosmidomycinuptakeintoplasmodiumandbabesiainfectederythrocytesisfacilitatedbyparasiteinducednewpermeabilitypathways
_version_ 1718424254732566528